富国恒生港股通创新药及医疗保健ETF发起式联接C(020111)份额变动
| 截止日 |
期初份额(份) |
期末份额(份) |
期间申购份额(份) |
期间赎回份额(份) |
| 2025-09-29 |
379,981,775.56 |
420,625,762.82 |
966,566,715.61 |
925,922,728.35 |
| 2025-06-29 |
219,007,647.07 |
379,981,775.56 |
821,649,023.98 |
660,674,895.49 |
| 2025-03-30 |
13,828,847.12 |
219,007,647.07 |
262,712,966.19 |
57,534,166.24 |
| 2024-12-30 |
10,706,551.30 |
13,828,847.12 |
25,318,099.28 |
22,195,803.46 |
| 2024-09-29 |
9,120,541.50 |
10,706,551.30 |
12,379,161.56 |
10,793,151.76 |
| 2024-06-29 |
8,031,563.60 |
9,120,541.50 |
29,975,531.16 |
28,886,553.26 |
| 2024-03-30 |
645,405.08 |
8,031,563.60 |
19,489,021.73 |
12,102,863.21 |
微信公众号
证券之星APP
基本资料
